Scout | Avant Garde/Avenir Awards: High-Risk, High-Reward HIV and Substance Use Research (DP1, trial optional)

This opportunity is no longer accepting applications.

nofo

Avant Garde/Avenir Awards: High-Risk, High-Reward HIV and Substance Use Research (DP1, trial optional)

This NOFO supports innovative, high-risk, high-impact research aimed at improving HIV prevention, diagnosis, treatment, and viral suppression for people who use substances and/or have substance use disorders. Funding can cover basic, clinical, translational, and implementation science, with a clinical trial optional for DP1 applications. Projects should be transformative and advance new strate…

Source

Agency: National Institutes of Health

Eligibility

small_business

tribal

nonprofit

university

government

For profit organizations other than small businesses

Native American tribal governments (Federally recognized)

Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education

Private institutions of higher education

State governments

Keywords

hiv

substance use

high-risk research

translational science

implementation science

clinical trial optional

prevention diagnosis treatment

viral suppression

Supporting Links

Documents

Similar Opportunities

Unlock similar opportunities

Get the full picture on this opportunity

Create a free Scout account to unlock everything you need to decide fast and win the grant.

Instant Fit Analysis

Let our grant expert AI score how well this opportunity aligns with your organization, strengths, gaps, and how to improve your chances of winning funding.
Deep agency & funder detail

Program context, sub-agency structure, and a full eligibility breakdown.
Source links & full documents

Jump straight to the solicitation and download every attachment.
Similar opportunities

Discover related funding matched to your work.

Get a Demo Sign Up

Already have an account? Sign In

Trusted by 500+ Happy Customers